Is This the “Ozempic of Alcohol”? How an Old, Affordable Drug May Help People Drink Less
For years, the conversation around medications and addiction has focused on developing entirely new treatments. But one of the most interesting possibilities in alcohol-use treatment is not a brand-new drug at all. It is naltrexone, a medication that has been available for decades and is already approved in the United States for alcohol use disorder.
Because naltrexone can reduce alcohol cravings and make drinking less rewarding for some people, it has increasingly been compared in popular headlines with the appetite-suppressing effects of drugs such as Ozempic. The comparison is catchy, but it needs an important qualification: naltrexone is not an “Ozempic for alcohol,” and it does not work in the same way as a GLP-1 medication. Rather, it acts on the brain’s opioid-receptor system and can reduce some of the rewarding effects associated with alcohol. (SAMHSA)
The drug has attracted renewed attention partly because of its low cost. Depending on the pharmacy, insurance coverage, and prescription arrangement, generic naltrexone can be inexpensive, sometimes costing only a small amount per tablet. That affordability stands in sharp contrast to the attention and expense surrounding some newer medications.
So what exactly does naltrexone do, and why are researchers and clinicians interested in it?
What Is Naltrexone?
Naltrexone is a prescription medication originally developed to help treat opioid use disorder. It works by blocking opioid receptors in the brain.
That may sound unrelated to alcohol. Alcohol is not an opioid, after all.
But alcohol interacts with the brain’s reward system in complicated ways. Drinking can stimulate the release of endogenous opioids, which contribute to pleasurable and reinforcing effects. Naltrexone blocks opioid receptors, reducing some of that reward.
The result is not necessarily that a person suddenly dislikes alcohol. Instead, the experience can become less reinforcing, potentially making it easier to stop after one or two drinks rather than continuing to drink. SAMHSA notes that naltrexone can reduce alcohol cravings and the amount of alcohol consumed. (SAMHSA)
That distinction is important.
Naltrexone is not a magic pill that eliminates addiction. It is one tool that can be incorporated into a broader treatment plan.
Why People Call It the “Ozempic of Alcohol”
The nickname comes from an understandable similarity.
GLP-1 medications such as semaglutide can reduce appetite and alter the brain’s response to food-related rewards. Researchers have become interested in whether these medications might also influence reward pathways associated with alcohol.
Naltrexone is older and works through a completely different biological mechanism, but it can also reduce the rewarding effects associated with a substance.
That has led to comparisons between the two.
However, researchers caution against treating the nickname as a scientific description. GLP-1 drugs and naltrexone are not interchangeable, and the evidence supporting naltrexone for alcohol use disorder is much more established than the evidence for using semaglutide specifically as an alcohol treatment.
A 2025 randomized clinical trial of once-weekly semaglutide investigated alcohol-related outcomes, reflecting growing scientific interest in GLP-1 medications. But the researchers themselves described the alcohol-treatment question as an emerging area requiring further study. (JAMA Network)
Naltrexone, meanwhile, has decades of research behind it.
How Naltrexone Can Change Drinking
One of the most interesting aspects of naltrexone is that the goal does not necessarily have to be immediate, lifelong abstinence.
For some people, the goal may be to drink less.
Clinical research has found that naltrexone can reduce heavy drinking and alcohol consumption, although the average effects are generally modest and vary substantially between individuals. (PubMed Central (PMC))
This matters because alcohol-use problems exist on a spectrum.
Someone might recognize that their drinking has become excessive without being ready—or able—to stop drinking completely. A medication that helps reduce cravings or makes it easier to limit consumption may therefore provide an additional option.
Research has even examined targeted use, in which naltrexone is taken around situations when a person expects a strong temptation to drink. A University of California summary of research reported that targeted naltrexone reduced binge drinking when taken as needed before situations associated with drinking. (University of California)
That does not mean everyone should take the medication only occasionally. Treatment decisions depend on the individual’s circumstances and should be made with a qualified clinician.
It Has Been Around for Decades
Perhaps the most surprising part of the story is that naltrexone isn’t new.
The medication was FDA-approved for alcohol use disorder decades ago. Yet medications for alcohol-use disorder remain substantially underused compared with their potential role in treatment.
A 2024 analysis noted that fewer than 10% of people with alcohol use disorder receive any treatment in a given year, while fewer than 3% receive medications for it. (JHEOR)
That means one of the biggest obstacles may not simply be discovering another medication.
It may be getting effective existing treatments to the people who could benefit from them.
Why It Can Be Helpful
Alcohol cravings can be powerful.
For someone trying to change their drinking, the hardest moment may not occur hours after drinking. It may happen when they see a favorite drink, enter a familiar bar, finish a stressful day, or encounter a social situation where alcohol has become part of the routine.
Those cues can trigger anticipation and craving.
Naltrexone may weaken the connection between those cues and the rewarding effects of alcohol. By reducing reinforcement, the medication can potentially make it easier for some people to interrupt the cycle.
Research has found reductions in drinking days, heavy drinking, and cravings among people treated with naltrexone, although the magnitude of benefit differs from person to person. (Psychiatry Online)
This variability is important.
A medication that works extremely well for one person may have little effect on another.
It Isn’t a Cure
Calling naltrexone the “Ozempic of alcohol” may make for a compelling headline, but it can also create unrealistic expectations.
Naltrexone does not erase addiction.
It does not guarantee sobriety.
It does not prevent intoxication.
And it does not make heavy drinking safe.
Mayo Clinic describes naltrexone as part of a broader treatment program that may include counseling, support groups, and other recommended interventions. (Mayo Clinic)
For many people, the best approach combines medication with behavioral strategies and ongoing support.
The goal is not simply to swallow a pill and hope everything changes.
The goal is to give someone another tool for changing a difficult pattern.
What About the Price?
The low price is another reason naltrexone has attracted attention.
Generic medications can cost dramatically less than many newer brand-name therapies, although the actual amount a person pays depends on insurance, pharmacy pricing, location, dosage, and other factors.
That means claims such as “less than $2 a pill” should not be interpreted as a universal price. The New York Post recently highlighted the low-cost nature of generic naltrexone while popularizing the “Ozempic of alcohol” comparison. (New York Post)
Still, the broader point is significant.
An inexpensive medication that has been studied for decades could potentially play a larger role in addressing alcohol-related harm.
Who Might Benefit?
Naltrexone is generally considered for people with alcohol use disorder who want to reduce drinking or maintain abstinence, depending on their individual treatment goals.
Some research suggests that people whose drinking is strongly motivated by alcohol’s pleasurable or rewarding effects may respond particularly well to the medication. Other research has explored whether particular characteristics can help predict who benefits most. (JHEOR)
This is part of a larger movement toward personalized addiction medicine.
Instead of asking, “Does this medication work for everyone?” researchers increasingly ask, “Which patients are most likely to benefit from this medication, and why?”
That approach could eventually make treatment more effective.
There Are Important Safety Considerations
Naltrexone is not appropriate for everyone.
Because it blocks opioid receptors, it can interfere with opioid pain medications and other opioid drugs. People using opioids need medical guidance before starting it, and clinicians generally need to consider opioid exposure and dependence carefully.
The medication can also cause side effects. Nausea, abdominal discomfort, headache, dizziness, and sleep-related symptoms are among the effects that may occur. Liver considerations are also important, particularly in people with existing liver disease or those taking inappropriate doses. MedlinePlus warns that high doses can cause liver damage and advises people with liver disease to discuss their condition with a clinician. (MedlinePlus)
These issues are why naltrexone should be obtained and used under appropriate medical supervision.
And one particularly important point is that naltrexone does not make alcohol intoxication harmless. A person can still become impaired after drinking.
What About Ozempic and Other GLP-1 Drugs?
This is where the story becomes even more interesting.
Researchers are investigating whether GLP-1 receptor agonists could eventually become useful tools for alcohol use disorder.
Some observational research and early clinical studies have produced intriguing signals. Researchers are particularly interested in whether GLP-1 medications might influence the brain’s reward pathways and reduce alcohol cravings or consumption.
But this research is still developing.
A 2025 randomized trial examined semaglutide’s effects in adults with alcohol use disorder, reflecting the growing scientific interest in the possibility. Yet GLP-1 medications should not currently be presented as established replacements for approved alcohol-use-disorder treatments. (JAMA Network)
Naltrexone has a much longer track record in this particular area.
A Bigger Lesson About Addiction Treatment
Perhaps the most important message behind the “Ozempic of alcohol” story is not about one miracle medication.
It is about changing the way society thinks about alcohol use disorder.
For decades, people have sometimes treated problematic drinking as nothing more than a failure of willpower. Modern medicine paints a much more complicated picture.
Addiction involves brain chemistry, reward pathways, learned behaviors, environment, genetics, stress, social circumstances, and many other factors.
Medication can therefore be a legitimate part of treatment.
Naltrexone is an example of that approach.
It doesn’t replace determination. It doesn’t replace counseling. It doesn’t remove every challenge.
But for some people, it may reduce the biological pull toward alcohol enough to make other changes possible.
The Bottom Line
So, is naltrexone really the “Ozempic of alcohol”?
Not literally.
The comparison is a media nickname, not a scientific classification. Ozempic and naltrexone work through different biological pathways, and GLP-1 medications are still being studied for alcohol-related uses.
But the underlying idea—that medication can reduce the reward or craving associated with alcohol—is real.
Naltrexone is an established prescription treatment for alcohol use disorder. Evidence shows that it can reduce alcohol cravings and heavy drinking for some people, although its effects are not universal and are generally modest on average. (SAMHSA)
Its long history and relatively low generic cost make it particularly interesting.
The bigger story may be that an effective tool has been available for years while many people who could benefit from medication never receive it.
For someone struggling with alcohol, the most important takeaway isn’t to chase a trendy headline or self-medicate. It is to know that evidence-based treatment options exist.
A conversation with a healthcare professional can help determine whether naltrexone—or another treatment—makes sense.
Sometimes progress doesn’t begin with a revolutionary new drug.
Sometimes it begins with recognizing that an existing tool may have been overlooked.
